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Abstract 
The viability of any organism relies greatly on their ability to adapt their metabolic 
processes in response to environmental stimuli. Proteins are essential for almost every 
intracellular biological process. Proteins are composed of amino acid precursors and the 
levels of amino acids within the cell available for protein synthesis requires careful 
monitoring. Amino acid conservation needs to be initiated in response to declining 
availability. Under conditions of amino acid deprivation, cessation of non-essential 
protein synthesis and activation of amino acid biosynthetic pathways is initiated. This 
regulatory mechanism is referred to as the General Amino Acid Control (GAAC) 
pathway.  
General control non-derepressible 2 (Gcn2) is a fundamental constituent of the GAAC 
response pathway. Gcn2 senses a decline in amino acid availability and initiates the 
stress response by phosphorylating the alpha subunit of eukaryotic translation initiation 
factor 2 (eIF2α). The phosphorylation of eIF2α triggers a sequence of events resulting in 
increased translation of the transcriptional activator Gcn4, which subsequently induces 
selective expression of genes necessary for de novo amino acid synthesis. 
The activation and activity of Gcn2 is moderated by inhibitory and facilitative protein 
interactions. Published large scale purification studies identified many novel Gcn2 
binding partners, some of which may function in Gcn2 regulation. However known 
Gcn2 regulators were absent from these datasets indicating that they were incomplete.  
This work aimed to identify and screen potential Gcn2 binding partners for those that 
regulate Gcn2 activity. Analysis identified 135 proteins that were potentially in complex 
with Gcn2. Of those, Sse1, Chs5, Ncl1, Tir4 and Npr1 were subsequently identified as 
potential Gcn2 regulators.  
For the purpose of comprehensively identifying novel Gcn2 binding proteins, a protocol 
was successfully optimised to enable Gcn2 affinity purification under conditions that 
would be specifically conducive for the maintenance of bonds between Gcn2 and its 
interaction partners. In this method, Gcn2 was overexpressed in cells to drive weak 
and/or transient interactions, and the usage of formaldehyde to crosslink interactions 
and further stabilise them was explored. This method will enable the future compilation 
of a comprehensive Gcn2 interactome. 
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